Charles River Associates

Meet Our Women@CRA ERG Leaders! In 2015, a group of colleagues came together to launch Women@CRA, an employee resource group dedicated to supporting and empowering women across our firm. Since its inception, Women@CRA has become a catalyst for engagement and growth, providing a valuable forum where women (and their allies) can connect, share insights, and elevate their skills in an inclusive, supportive environment. Today, we’re excited to introduce the 2024 Women@CRA leadership team, who embody our commitment to fostering an inclusive and engaged culture at CRA. Meet the Leaders: Miri Davidson – Co-Chair (U.S.) Principal, Forensic Services With over 18 years of experience, Miri leads complex, high-profile investigations for Am Law 100 firms, Fortune 500 companies, and government agencies like the Department of Justice. She brings a data-driven, analytical approach to eDiscovery and compliance, and her commitment to Women@CRA reflects her dedication to creating spaces for professional growth and collaboration. Dahlia (Aronson) Ehrenfried – Co-Chair (U.S.) Senior Director, Marketing, Business Development, and Coaching (MBDC) Dahlia is a marketing strategist with nearly 30 years of experience and an MBA from Boston University. She is known for her expertise in developing client-focused marketing strategies and driving business growth in professional services. As Co-Chair, Dahlia is committed to helping CRA colleagues harness their skills and achieve their professional goals. Cécile Matthews – Executive Sponsor Vice President, Life Sciences With over 25 years of strategic consulting experience in life sciences, Cécile is an expert in pricing, reimbursement, and market access. Her deep knowledge of the global and French healthcare landscapes allows her to guide clients through complex challenges. As Executive Sponsor of Women@CRA, Cécile champions initiatives that support women’s advancement and amplify their impact. These leaders embody CRA's dedication to creating an inclusive, engaged workplace where every voice is valued. Join us in celebrating the impactful work of Women@CRA and the leadership of this exceptional team. #WomenatCRA #InclusiveLeadership #ERGsAtCRA #CRAlwaysEngaged #BelongingAtCRA

The Annual CRA Brussels Conference returns to the Steigenberger Wiltcher’s Hotel on Tuesday, 10 December 2024. This year’s conference will address regaining competitiveness—boom or bust for competition policy? The conference will also include sessions on critical developments in mergers, technology and AI regulation, the evolution of economic analysis of antitrust, the DMA, and more. To register for this event and join us in Brussels, click here: https://lnkd.in/eQZu-shb #CRACompetition #BrusselsConference #Antitrust

#CRACompetition's Elizabeth Bailey will be debating during the session titled “Merger Efficiencies Are Over-Promised and Under-Delivered” at the ABA 2024 Antitrust Fall Forum. To learn more about the event, click here: https://crai.news/duf #CRASpeaks

CRA is a proud sponsor of the ABA’s 18th Annual Labor and Employment Law Conference which will offer cutting-edge and in-depth programs covering developments across the full range of labor and employment law topics along with numerous networking opportunities. To learn more about this event, click here: https://crai.news/ckz #CRALaborEmployment

In the latest edition of #CRACompetition's IP Literature Watch, Tolga Bilgicer and Arun Maganti explore a range of topics on antitrust & IP, licensing, litigation, innovation, law and policy, copyright, and trade. To read the full CRA Insight’s, click here: https://crai.news/hwk

On October 31, 2024, the European Commission imposed a €462.6 million fine on Teva for delaying competition for its multiple sclerosis treatment, Copaxone, across seven EU Member States. #CRACompetition’s Raphaël De Coninck and Elina Koustoumpardi advised third parties in this pivotal case, in which the Commission found that Teva misused the patent system by creating a “web of secondary patents” to obstruct rivals and prevent market entry. Additionally, the Commission found that Teva disseminated misleading information about the safety and efficacy of a competitor’s product, despite that product having received regulatory approval as a safe and bioequivalent product to Teva’s Copaxone. This marks the first Commission fine for these specific practices. To learn more, click here: https://crai.news/osg

Since 2020, nearly 100 utility companies have faced credit rating downgrades due to rising wildfire risks, making borrowing tougher and increasing costs for consumers. #CRAEnergy’s Andrew Dressel, cited in Utility Dive, notes that effective wildfire mitigation is reducing legal risks. With careful planning and policy support, utilities could stabilize their credit outlook despite these challenges. To read the full article, click here: https://crai.news/wlv #WildfireRisk #UtilityRates

Infertility is a growing public health concern, affecting one in six people globally, according to the World Health Organization (WHO). Declining fertility rates in economically developed countries, especially in Europe and the Asia-Pacific region, have increased focus on the societal and individual impacts of infertility. This European Fertility Week, #CRALifeSciences’s Ryan Lawlor, Hannah Armstrong, and Angelina P. explore the challenges surrounding access to treatment and the socioeconomic implications, providing actionable recommendations to improve quality of life and access to care for women facing infertility. Their insights underscore the need for coordinated actions by global and national leaders to address these critical issues. To learn more, click here: https://crai.news/krs

CRA is honored to sponsor and attend the 2024 POWERful Women Annual Conference, a pivotal event advancing gender balance and diversity in the UK energy sector. We hope to see many of you there today to celebrate the 10th anniversary of POWERful Women and support their goal of reaching 40% female representation in leadership and middle management by 2030. To learn more about this event, click here: https://crai.news/h8r

In a recent article titled, “Smallest saleable patent-practicing unit in life sciences disputes,” #CRALifeSciences Erin McDermott explores calculating damages in IP disputes by focusing on “reasonable royalties” for patent infringement. McDermott highlights the challenge of determining an appropriate “royalty base” for multicomponent products, often limited to the smallest saleable patent-practicing unit (SSPPU). While traditionally used in tech, SSPPU is increasingly relevant in life sciences as combination products become more common, suggesting a broader application for SSPPU-based royalty calculations in IP cases. To read the full article, click here: https://crai.news/i1z